Law Offices of Scott Glovsky

Law Offices of Scott Glovsky The Law Offices of Scott Glovsky was founded in 1999 and specializes in health insurance denials, insurance bad faith, catastrophic injuries, and more.

A growing number of families are being hit with massive surprise bills for therapy as some providers allegedly engage ...
06/02/2026

A growing number of families are being hit with massive surprise bills for therapy as some providers allegedly engage in excessive or fraudulent billing practices. One New Jersey mother was billed more than $911,000 after her insurer denied claims for her son’s treatment, highlighting concerns about unregulated providers charging extraordinary rates, billing for questionable services, and pursuing families directly when insurers refuse payment. Experts warn that these practices are driving up costs and creating financial hardship for families seeking care for children with autism.

A new federal rule updates the No Surprises Act by simplifying the process for billing disputes and lowering filing fe...
06/01/2026

A new federal rule updates the No Surprises Act by simplifying the process for billing disputes and lowering filing fees from $115 to $15. While supporters say it reduces administrative burdens, insurers and consumer advocates warn it could encourage more disputes and allow some providers to secure higher payments, potentially driving up premiums and costs for consumers.

Drugmakers including Novartis, Amgen, and and Company are developing new treatments targeting lipoprotein(a), or Lp(a)...
05/28/2026

Drugmakers including Novartis, Amgen, and and Company are developing new treatments targeting lipoprotein(a), or Lp(a), a genetic form of bad cholesterol that increases the risk of , , and artery blockage. Unlike other cholesterol conditions, Lp(a) is largely inherited and cannot be lowered through diet or exercise. About 1 in 5 people worldwide have dangerously high levels, yet there are currently no approved treatments specifically designed to lower it. Researchers are hopeful that upcoming clinical trial results could finally prove that

GLP-1 weight-loss drugs like and have helped millions lose significant weight and improve health conditions, but som...
05/27/2026

GLP-1 weight-loss drugs like and have helped millions lose significant weight and improve health conditions, but some users report serious side effects, including fatigue and significant loss of muscle mass. Research suggests users may lose up to 10% of lean muscle, which can lead to weakness, frailty, and slower metabolism if not paired with strength training. Experts warn the drugs are often used without enough guidance on exercise or nutrition, raising concerns about long-term health impacts, especially for older adults and non-obese users.

A preliminary study published found that a single infusion of an experimental gene-editing reduced bad (LDL) cholester...
05/26/2026

A preliminary study published found that a single infusion of an experimental gene-editing reduced bad (LDL) cholesterol by up to 62 percent, potentially offering a permanent solution. By targeting and disabling the PCSK9 gene in the liver, the therapy could eventually become a "one-and-done" primary care approach to prevent . While the results are highly promising for patients who struggle with daily , experts emphasize that a larger 200-patient study and 15 years of safety data are required before the treatment can be widely approved.

Wishing everyone a meaningful Memorial Day as we remember and honor those who served and sacrificed.
05/25/2026

Wishing everyone a meaningful Memorial Day as we remember and honor those who served and sacrificed.

Employers are placing greater scrutiny on voluntary benefits like , hospital indemnity, and supplemental insurance plan...
05/25/2026

Employers are placing greater scrutiny on voluntary benefits like , hospital indemnity, and supplemental insurance plans as concerns grow over whether employees truly understand and use the they pay for. Instead of focusing mainly on low premiums and broad plan options, companies and brokers are now prioritizing benefit utilization — including easy claims processes, faster payouts, coverage aligned with modern healthcare practices, and support for issues like mental health and family caregiving. The shift is increasing pressure on brokers to prove these benefits provide real-world value and meaningful financial support for employees.

An Affordable Care Act enrollee accused of operating a ghost network after repeatedly finding that doctors listed as i...
05/22/2026

An Affordable Care Act enrollee accused of operating a ghost network after repeatedly finding that doctors listed as in-network did not actually accept the insurance, leaving her unable to secure care for her infant child. The issue has drawn broader attention to inaccurate provider directories in Marketplace health plans, as consumer advocates and lawmakers warn that misleading networks can leave patients paying premiums for coverage that offers little practical access to care. Several major insurers, including , , and UnitedHealth Group, have also faced legal scrutiny over alleged ghost networks and inaccurate provider listings.

Eli Lilly announced that its experimental obesity drug helped patients lose up to 30% of their body weight in a large ...
05/21/2026

Eli Lilly announced that its experimental obesity drug helped patients lose up to 30% of their body weight in a large clinical trial, with some patients losing an average of 85 pounds over two years — results comparable to gastric bypass surgery. The weekly injection outperformed current weight-loss drugs like and , though higher doses were linked to significant gastrointestinal side effects that caused some participants to stop treatment.

A Virginia woman says her insurance company denied a that later revealed Stage IV metastatic , after initially determ...
05/20/2026

A Virginia woman says her insurance company denied a that later revealed Stage IV metastatic , after initially determining the lesion on her lung was not large enough to warrant testing. The case has renewed concerns over rising health insurance claim denials, as recent data showed insurers rejected nearly 1 in 5 in-network claims in 2023, with marketplace plans reporting higher denial rates than Medicare or . Experts warn that delayed approvals and coverage denials can lead to serious health consequences, significant out-of-pocket costs, and treatment delays for patients.

Address

299 N. Euclid Avenue, 2nd Floor
Pasadena, CA
91101

Telephone

+16262435598

Website

Alerts

Be the first to know and let us send you an email when Law Offices of Scott Glovsky posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Law Offices of Scott Glovsky:

Shortcuts

Share

Category